Premium
Pharmacogenetic Information in Clinical Guidelines: The European Perspective
Author(s) -
Swen Jesse J.,
Nijenhuis Marga,
Rhenen Mandy,
BoerVeger Nienke J.,
Buunk AnneMarie,
Houwink Elisa J.F.,
Mulder Hans,
Rongen Gerard A.,
Schaik Ron H.N.,
Weide Jan,
Wilffert Bob,
Deneer Vera H.M.,
Guchelaar HenkJan
Publication year - 2018
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.1049
Subject(s) - pharmacogenomics , pharmacogenetics , test (biology) , health professionals , perspective (graphical) , health care , medicine , family medicine , psychology , pharmacology , computer science , political science , paleontology , biochemistry , chemistry , artificial intelligence , biology , genotype , law , gene
Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx). 1‐3 In addition, patients are willing to consent to participate in PGx implementation studies. 4 However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test. 1,2 Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients. 5,6